These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Advances and Potential Applications of Chitosan Nanoparticles as a Delivery Carrier for the Mucosal Immunity of Vaccine. Li D; Fu D; Kang H; Rong G; Jin Z; Wang X; Zhao K Curr Drug Deliv; 2017; 14(1):27-35. PubMed ID: 27494157 [TBL] [Abstract][Full Text] [Related]
44. Oral delivery of peptide drugs using nanoparticles self-assembled by poly(gamma-glutamic acid) and a chitosan derivative functionalized by trimethylation. Mi FL; Wu YY; Lin YH; Sonaje K; Ho YC; Chen CT; Juang JH; Sung HW Bioconjug Chem; 2008 Jun; 19(6):1248-55. PubMed ID: 18517235 [TBL] [Abstract][Full Text] [Related]
45. Potential of chitosan-based carrier for periodontal drug delivery. Sah AK; Dewangan M; Suresh PK Colloids Surf B Biointerfaces; 2019 Jun; 178():185-198. PubMed ID: 30856588 [TBL] [Abstract][Full Text] [Related]
46. Physicochemical, pharmaceutical and biological approaches toward designing optimized and efficient hydrophobically modified chitosan-based polymeric micelles as a nanocarrier system for targeted delivery of anticancer drugs. Mahmoudzadeh M; Fassihi A; Emami J; Davies NM; Dorkoosh F J Drug Target; 2013 Sep; 21(8):693-709. PubMed ID: 23915108 [TBL] [Abstract][Full Text] [Related]
48. Why chitosan could be apt candidate for glaucoma drug delivery - An overview. Kumara BN; Shambhu R; Prasad KS Int J Biol Macromol; 2021 Apr; 176():47-65. PubMed ID: 33581206 [TBL] [Abstract][Full Text] [Related]
49. Chitosan-based nanoparticles as delivery systems of therapeutic proteins. Fonte P; Andrade JC; Seabra V; Sarmento B Methods Mol Biol; 2012; 899():471-87. PubMed ID: 22735970 [TBL] [Abstract][Full Text] [Related]
50. Enhancement of oral bioavailability of salmon calcitonin through chitosan-modified, dual drug-loaded nanoparticles. Liu L; Yang H; Lou Y; Wu JY; Miao J; Lu XY; Gao JQ Int J Pharm; 2019 Feb; 557():170-177. PubMed ID: 30597264 [TBL] [Abstract][Full Text] [Related]
51. Alginate/chitosan microparticles for gastric passage and intestinal release of therapeutic protein nanoparticles. Ling K; Wu H; Neish AS; Champion JA J Control Release; 2019 Feb; 295():174-186. PubMed ID: 30557649 [TBL] [Abstract][Full Text] [Related]
52. Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel. Shi LL; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR Drug Dev Ind Pharm; 2017 May; 43(5):839-846. PubMed ID: 27487431 [TBL] [Abstract][Full Text] [Related]
53. Insulin-loaded mucoadhesive nanoparticles based on mucin-chitosan complexes for oral delivery and diabetes treatment. Mumuni MA; Kenechukwu FC; Ofokansi KC; Attama AA; Díaz DD Carbohydr Polym; 2020 Feb; 229():115506. PubMed ID: 31826394 [TBL] [Abstract][Full Text] [Related]
54. Ionically Cross-Linked Chitosan Nanoparticles for Sustained Delivery of Docetaxel: Fabrication, Post-Formulation and Acute Oral Toxicity Evaluation. Mahmood MA; Madni A; Rehman M; Rahim MA; Jabar A Int J Nanomedicine; 2019; 14():10035-10046. PubMed ID: 31908458 [TBL] [Abstract][Full Text] [Related]
55. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery. Mahmoud AA; El-Feky GS; Kamel R; Awad GE Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097 [TBL] [Abstract][Full Text] [Related]
56. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles. Ahmad N; Ahmad R; Alam MA; Ahmad FJ; Amir M; Pottoo FH; Sarafroz M; Jafar M; Umar K Int J Biol Macromol; 2019 May; 128():825-838. PubMed ID: 30690115 [TBL] [Abstract][Full Text] [Related]
57. Enhancing Stability and Mucoadhesive Properties of Chitosan Nanoparticles by Surface Modification with Sodium Alginate and Polyethylene Glycol for Potential Oral Mucosa Vaccine Delivery. Amin MK; Boateng JS Mar Drugs; 2022 Feb; 20(3):. PubMed ID: 35323455 [No Abstract] [Full Text] [Related]
58. Biodegradable nanoparticles based on linoleic acid and poly(beta-malic acid) double grafted chitosan derivatives as carriers of anticancer drugs. Zhao Z; He M; Yin L; Bao J; Shi L; Wang B; Tang C; Yin C Biomacromolecules; 2009 Mar; 10(3):565-72. PubMed ID: 19175304 [TBL] [Abstract][Full Text] [Related]
59. Development and evaluation of chitosan and chitosan derivative nanoparticles containing insulin for oral administration. Hecq J; Siepmann F; Siepmann J; Amighi K; Goole J Drug Dev Ind Pharm; 2015; 41(12):2037-44. PubMed ID: 26006329 [TBL] [Abstract][Full Text] [Related]
60. Synthesis and characterization of a novel peptide-grafted Cs and evaluation of its nanoparticles for the oral delivery of insulin, in vitro, and in vivo study. Barbari GR; Dorkoosh F; Amini M; Bahari Javan N; Sharifzadeh M; Atyabi F; Balalaie S; Rafiee Tehrani N; Rafiee Tehrani M Int J Nanomedicine; 2018; 13():5127-5138. PubMed ID: 30233176 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]